Skip to main content

Table 2 Statistical association of TACSTD2 methylation and clinicopathological characteristics in logistic regression analyses

From: DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers

TACSTD2 methylation OR (95% CI) p-value
Metastasis (M0 vs. M1) 1.18 (1.05–1.35) 0.008
Lymph node status (N0 vs. N1) 1.21 (1.03–1.43) 0.021
Tumor stage (low vs. high T*) 1.18 (1.06–1.31) 0.003
Differentiation (low vs. high G**) 1.16 (1.01–1.34) 0.033
State of Disease (loc vs. adv***) 1.20 (1.08–1.34) < 0.001
  1. Abbreviations: vs versus
  2. OR odds ratio; 95% CI 95% confidence interval
  3. *Low defined as T1 and T2; high defined as T3 and T4
  4. ** Low defined as G1, G2; high defined as ≥G3
  5. ***Localized disease (loc) defined as pT ≤ 2, N0, M0; advanced disease (adv) defined as pT ≥ 3 and/or N1, M1